期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Machine Learning Prediction Models of Optimal Time for Aortic Valve Replacement in Asymptomatic Patients
1
作者 Salah Alzghoul Othman Smadi +2 位作者 Ali Al Bataineh Mamon Hatmal Ahmad Alamm 《Intelligent Automation & Soft Computing》 SCIE 2023年第7期455-470,共16页
Currently,the decision of aortic valve replacement surgery time for asymptomatic patients with moderate-to-severe aortic stenosis(AS)is made by healthcare professionals based on the patient’s clinical biometric recor... Currently,the decision of aortic valve replacement surgery time for asymptomatic patients with moderate-to-severe aortic stenosis(AS)is made by healthcare professionals based on the patient’s clinical biometric records.A delay in surgical aortic valve replacement(SAVR)can potentially affect patients’quality of life.By using ML algorithms,this study aims to predict the optimal SAVR timing and determine the enhancement in moderate-to-severe AS patient survival following surgery.This study represents a novel approach that has the potential to improve decision-making and,ultimately,improve patient outcomes.We analyze data from 176 patients with moderate-to-severe aortic stenosis who had undergone or were indicated for SAVR.We divide the data into two groups:those who died within the first year after SAVR and those who survived for more than one year or were still alive at the last follow-up.We then use six different ML algorithms,Support Vector Machine(SVM),Classification and Regression Tree(C and R tree),Generalized Linear(GL),Chi-Square Automatic Interaction Detector(CHAID),Artificial Neural Net-work(ANN),and Linear Regression(LR),to generate predictions for the best timing for SAVR.The results showed that the SVM algorithm is the best model for predicting the optimal timing for SAVR and for predicting the post-surgery survival period.By optimizing the timing of SAVR surgery using the SVM algorithm,we observed a significant improvement in the survival period after SAVR.Our study demonstrates that ML algorithms generate reliable models for predicting the optimal timing of SAVR in asymptomatic patients with moderate-to-severe AS. 展开更多
关键词 Aortic stenosis aortic valve replacement machine learning survival period enhancement artificial intelligence in cardiology
下载PDF
Combination of percutaneous radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: observation of clinical effects 被引量:22
2
作者 Hui-Chun Liu Er-Bo Shan +4 位作者 Lei Zhou Hao Jin Pei-Yuan Cui Yi Tan Yi-Min Lu 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2014年第4期471-477,共7页
Objective: To observe the clinical effect of radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) for advanced hepatocellnlar carcinoma (HCC). Methods: A total of 92 ease... Objective: To observe the clinical effect of radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) for advanced hepatocellnlar carcinoma (HCC). Methods: A total of 92 eases of advanced primary liver cancer underwent TACE and RFA treatment from June 2005 to 2011 at the Department of Hepatobiliary Surgery, the First Affiliated Hospital of Bengbu Medical College. A total of 88 cases with complete clinical treatment and follow-up data were divided into two groups: 43 patients treated with TACE (TACE group) and 45 patients that received TACE combined with RFA treatment (TACE + RFA group). After clinical data assessment, tumor size and survival status were not significantly different between the groups as determined by stratified analysis. Results: Before and after surgery, spiral CT radiography and color comparison observed ablation conditions. The tumor necrosis rates after treatment (CR + PR) were 67.4% (29/43) and 91.1% (41/45) for the TACE and combined treatment groups, respectively, and the difference was statistically significant (P〈0.05). The quality of life was significantly improved for patients undergoing TACE ~ RFA compared with the control group. Survival duration was not significantly different in patients undergoing TACE ~ RFA compared with the control group. Conclusions: In this study, the effect of RFA combined with TACE treatment was better than TACE alone in treating advanced HCC. 展开更多
关键词 Liver cancer radiofrequency ablation (RFA) transcatheter arterial chemoembolization (TACE) quality of life survival period
下载PDF
CLINICAL ANALYSIS OF 150 PATIENTS WITH PERIAMPULLARY CARCINOMA
3
作者 吴祥德 宋振川 +1 位作者 耿翠芝 李秉慧 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1995年第1期44-47,共4页
This article report 150 cases of patients with periampullary carcinoma,of them,the tumors of 85 cases were in the head of pancreas,26 in lower part of the common bileduct,21 in ampulla of Vater and 18 in duodenal papi... This article report 150 cases of patients with periampullary carcinoma,of them,the tumors of 85 cases were in the head of pancreas,26 in lower part of the common bileduct,21 in ampulla of Vater and 18 in duodenal papilla.Of 150 patients,paucreatoduodenectomy were performed in 53 cases but one had total pancreactomy,with a total resection rate of 36%.respectability was high in ampulla and duodenal papilla cancers,with a resection rate of 89.5% and 83.3%,respectively.The lowest resection rate 14.1%,was in patients with cancer in bead of the pancreas.Twenty cases had postoperative complications,the morbidity rate was 13.3%.Postoperative death occurred in 9 cases with a mortality rate of 6%.The follow-up results showed that the 3-year and 5-year survival rates of the resection group were 31.8% and 11.8% respectively.Fifty-four cases with resec-tions had a mean survival period of 16.7 months.Ampullary cartinoma group had the longest survival period,22.4 mouths,but non-resection group,all had bileinbestinal shunt only 4.8 mouths. 展开更多
关键词 Periampullary carcinoma SURGERY survival period.
下载PDF
Effect of Qinggan Huayu granule on H22 liver ascitic tumor mice
4
作者 Fei-Ya Suo Xiao-Ran Zhu +1 位作者 Zhen-Huan Yang Shu-Kun Yao 《Journal of Hainan Medical University》 2022年第9期1-7,共7页
Objective:To evaluate the therapeutic effect of Qinggan Huayu granule on mice with H22 liver cancer ascites tumor.Methods:A H22 liver cancer ascites mouse model was established by intraperitoneally injecting H22 liver... Objective:To evaluate the therapeutic effect of Qinggan Huayu granule on mice with H22 liver cancer ascites tumor.Methods:A H22 liver cancer ascites mouse model was established by intraperitoneally injecting H22 liver cancer cells.Mice were randomly divided into the model group,the Ganfule group(1.35 g/kg),the fluorouracil group(50 mg/kg i.p),the Qinggan Huayu granule groups at low(0.67 g/kg),medium(1.34 g/kg),and high(2.68 g/kg)doses.Then the mice were administered continuously for 10 days and body weight and abdominal circumference were monitored every 3 days.On day 11,eight rats in each group were randomly selected for dissection to detect the amount of peritoneal water,peritoneal permeability and histopathological changes.The remaining mice were observed for survival.In addition,the vascular endothelial growth factor A(VEGFA)and vascular endothelial growth factor receptor 2(VEGFR2)were determined by Western blotting.Results:Compared with the model group,the weight growth of mice in the fluorouracil group and the medium-dose and high-dose Qinggan Huayu granule groups was slower(P<0.05).Moreover,the abdominal circumference of mice in each treatment group was increased slowly.There were significant differences in abdominal circumference between the fluorouracil group,the medium-dose group and the control group from day 6(P<0.05)while the abdominal circumference of the high dose group was significantly smaller than that of the control group from day 12(P<0.05).Moreover,compared with the model group,the amount of ascites in the medium-and high-dose Qinggan Huayu granule groups was decreased significantly(P<0.05).The optical density value of ascites supernatant in medium-and high-dose Qinggan Huayu granule group and the fluorouracil group decreased significantly(P<0.05)and the survival period of the medium-dose Qinggan Huayu granule group and the fluorouracil group was prolonged prominently(P<0.05).There was no significant difference in the low-dose Qinggan Huayu granule group and the Ganfule group.Peritoneal histopathological assay showed more complete peritoneal structure,less edema and less angiogenesis of the peritoneum in the fluorouracil group and the medium-and high-dose Qinggan Huayu granule group,which was better than that of the Ganfule group and the low-dose group.Compared with the model group,the expressions of VEGFA and VEGFR2 in the medium-dose Qinggan Huayu granule group decreased significantly(P<0.05,P<0.01).Conclusion:Qinggan Huayu granule can inhibit ascites production in the mice model with H22 liver cancer ascites tumor,prolong the survival of mice,and reduce peritoneal permeability and suppress the increase of peritoneal neovascularization.The mechanism may be related to the inhibition of VEGF/VEGFR pathway. 展开更多
关键词 H22 liver cancer ascites tumor Mouse Qinggan Huayu granule survival period Peritoneal vascular permeability
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部